🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a 2-part, open-label, single-center relative bioavailabi...
Status
Completed
Location
Research Site
Start Date
2020-06-24
Trial ID
NCT04488016
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
To evaluate the tolerability,feasibility, and efficacy of combining acalabr...
Status
Unknown
Location
Swedish Cancer Institute
Start Date
2019-08-16
Trial ID
NCT03736616
This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Start Date
2017-06-26
Trial ID
NCT03162536
Treatments Being Tested
This study will evaluate the effect of fluconazole and isavuconazole on the...
Status
Completed
Location
Celerion
Start Date
2020-01-03
Trial ID
NCT05140096
Treatments Being Tested
This research is being done to assess the effectiveness and safety of acala...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-03-01
Trial ID
NCT05583149
Treatments Being Tested
This study is to evaluate the effects of single therapeutic and supratherap...
Status
Completed
Location
Celerion
Start Date
2016-04-01
Trial ID
NCT04867980
Treatments Being Tested
This study is being conducted to support the clinical development of acalab...
Status
Completed
Location
Research Site
Start Date
2020-05-22
Trial ID
NCT04435483
Treatments Being Tested
This Primary objective is evaluating the efficacy of obinutuzumab in combin...
Status
Active Not Recruiting
Location
Research Site
Start Date
2015-06-26
Trial ID
NCT02475681
Treatments Being Tested